<DOC>
	<DOCNO>NCT00909883</DOCNO>
	<brief_summary>Foot dystonia frequently observe patient suffer Parkinson'disease . It characterize abnormal involuntary movement uncomfortable ( difficult walk ) painful patient . Botulinum toxin injection seem efficient treat dystonia . However study topic imprecise ( many muscle inject , especially Flexor digitorum longus , different dos use , heterogeneous population many type dystonia include , open study ) .</brief_summary>
	<brief_title>Foot Dystonia Treatment Botulinum Toxin Injections Parkinson Disease : Efficiency Injections Made Extrinsic Muscle ( Flexor Digitorum Longus Muscle ) Compared Intrinsic Muscle ( Flexor Digitorum Brevis Quadratus Plantae Muscles )</brief_title>
	<detailed_description>Study progress : After inclusion visit , patient randomize one 3 follow group : - First group ( PL : placebo ) : - J0 : Patient receive 1 injection placebo Flexor digitorum longus 1 injection placebo Flexor digitorum brevis quadratus plantae - J+1month : First evaluation - J+3 month : Patient receive 1 injection placebo Flexor digitorum longus 1 injection placebo Flexor digitorum brevis quadratus plantae - J+4 month : Last evaluation - Second group ( ME : Extrinsic muscle ) - J0 : Patient receive 1 injection Botulinum toxin ( 100U ) Flexor digitorum longus 1 injection placebo Flexor digitorum brevis quadratus plantae - J+1 month : First evaluation - J+3 month : Patient receive 1 injection Botulinum toxin ( 100U ) Flexor digitorum longus 1 injection placebo Flexor digitorum brevis quadratus plantae - J+4 month : Last evaluation - Third group ( MI : Intrinsic muscle ) - J0 : Patient receive 1 injection placebo Flexor digitorum longus 1 injection Botulinum toxin ( 100U ) Flexor digitorum brevis quadratus plantae - J+1 month : First evaluation - J+3 month : Patient receive 1 injection placebo Flexor digitorum longus 1 injection Botulinum toxin ( 100U ) Flexor digitorum brevis quadratus plantae - J+4 month : Last evaluation During injection ( J0 J+3M ) , measure pain induced injection ( EVA ) For evaluation ( J+1M J+4M ) , follow evaluation make : clinical improvement ( CGI ) , dystonia evaluation ( duration severity , Burke scale ) , pain ( EVA ) quality life ( PDQ39 ) .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Age : 3075 year Patient idiopathic Parkinson 's disease accord criterion `` Parkinson 's Disease Society Brain Bank '' Patient unilateral tiptoe dystonia . Dystonia must present 1h /day induce difficulty walk ( severity index â‰¥ 3 ( 1 : light , 2 : moderate , 3 : severe , 4 : severe ) ) . Patients never treat botulinum toxin already treat 6 month . Affiliation social security Agreement patient Patients suffer atypical Parkinson syndrome Patient bilateral tiptoe dystonia Patients contraindication botulinum toxin use Women without efficient contraception Person participate study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Idiopathic Parkinson 's disease</keyword>
	<keyword>Foot ( Tiptoe ) dystonia</keyword>
	<keyword>Botulinum Toxin</keyword>
	<keyword>Muscles : Flexor digitorum longus/ Flexor digitorum brevis/ quadratus plantae</keyword>
</DOC>